Inhibition of fatty acid amide hydrolase (FAAH), which degrades endogenous cannabinoids, may also be of great importance in the treatment of Alzheimer’s disease [86,91]. This evidence concerns the gene FAAH and early-onset autosomal dominant Alzheimer disease.